Roche: Phase 3 OCREVUS High-Dose Study in People With Relapsing Multiple Sclerosisdid Didn't Meet Primary Endpoint
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
Tesla shares up with Musk’s White House days reported to be numbered
Tesla's stock was rising late Wednesday morning as a published report indicated that CEO Elon Musk would be leaving his Trump administration role in the coming weeks. Politico reported that Presiden ...
Trump still cares about stocks, according to optimistic take from Fundstrat
Though the confidence of many market participants has taken a recent hit over uncertainty about the impact of U.S.-imposed tariffs, one rather optimistic view is currently emerging. As Barbara ...
Trump’s ‘liberation day’ tariffs to come after stock market’s close, as taxes on imports stack up
What President Donald Trump has billed as “liberation day” is here, but investors may need to wait until after the stock ...
Superior Plus Shares Climb on Upgraded Outlook Through 2027
Adjusted net income is also expected higher, at 65 cents a share, up from 16 cents a share in 2024--representing a 60% growth rate compounded annually. Free cash flow is expected to rise to $240 ...